Related Experiment Videos
Evidence for two somatostatin-14 receptor types in rat brain cortex
Neuroscience Letters
|August 31, 1984
Summary
A new study shows SMS 201-995, a somatostatin analogue, can help differentiate somatostatin receptor types. This finding is crucial for understanding receptor populations in the brain and pancreas.
Area of Science:
- Pharmacology
- Neuroscience
- Endocrinology
Background:
- Somatostatin receptors play critical roles in various physiological processes.
- Understanding the subtypes and distribution of somatostatin receptors is essential for therapeutic development.
Purpose of the Study:
- To evaluate the binding characteristics of the stable somatostatin analogue, SMS 201-995.
- To investigate the potential of SMS 201-995 in differentiating somatostatin receptor subtypes.
Main Methods:
- Somatostatin receptor binding assays were performed using [125I-Tyr11]somatostatin.
- Binding affinities were determined for SMS 201-995 and somatostatin-14 in rat cortical, pituitary, and pancreatic beta-cell membranes.
Main Results:
- High-affinity binding sites for both somatostatin-14 and SMS 201-995 were identified in all tested tissues.
- SMS 201-995 labeled only approximately 75% of somatostatin-14 receptors in the cortex, suggesting heterogeneity.
- Binding affinities (Kd) were 0.60 nM (cortex), 0.74 nM (pituitary), and 0.18 nM (pancreatic beta-cells) for SMS 201-995.
Conclusions:
- SMS 201-995 exhibits high affinity for somatostatin receptors in the cortex, pituitary, and pancreas.
- The differential labeling in the cortex indicates the presence of multiple somatostatin receptor populations.
- SMS 201-995 serves as a valuable pharmacological tool for distinguishing between somatostatin receptor types.